Literature DB >> 15859181

The effectiveness of a body mass reduction program in obese women in perimenopausal and menopausal age compared with the effectiveness of such a program in younger (18-44 years of age) women living in Poland.

L Ostrowska1, M M Lech.   

Abstract

OBJECTIVE: The aim of the work was: to compare the effectiveness of body mass reducing program in women of perimenopausal (and menopausal) age with the effectiveness of such a program when it was applied to women aged 18-44 years.
METHODS: The paper deals with observation study of the group of obese patients recruited and treated in Bialystok's Clinical Center for Cardiology and Body Mass Reduction. The authors summarize 12 months of clinical observation (as it was initially planned) of the two groups of obese women, taking part in the special body mass reduction program; Group I - 81 women in perimenopausal and menopausal age, Group II - 107 women in 18-44 years of age. The proposed treatment contained diet, physical exercises, psychological support and pharmacotherapy.
RESULTS: The positive reaction for the treatment of obesity was less visible in obese women in perimenopausal and menopausal age, than in the group of obese women in 18-44 years of age (change of BMI in the group of younger women was -3.44 kg/m2 vs. -2.65 kg/m2 in older women). As it was observed, the weaker reaction for the proposed treatment in the group of older women, was not related to lower BMR, than in the group of younger obese women. Provisional result shows that use of HRT (Hormonal Replace Therapy) may probably result in better response of body mass reduction in perimenopausal and menopausal women.
CONCLUSION: The high dropout of the patients included into the study does not allow to formulate unequivocal conclusions but it seems that body mass reduction program for women in perimenopausal and menopausal age should concentrate on building the motivation of the patients, HRT may play some role in improvement of effectiveness of such program but this should be confirmed by further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15859181

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  14 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  Changing clinical behaviour by making guidelines specific.

Authors:  Susan Michie; Marie Johnston
Journal:  BMJ       Date:  2004-02-07

3.  Characteristics of effective clinical guidelines for general practice.

Authors:  Jako S Burgers; Richard P T M Grol; Joost O M Zaat; Teun H Spies; Akke K van der Bij; Henk G A Mokkink
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

Review 4.  Achieving health gain through clinical guidelines II: Ensuring guidelines change medical practice.

Authors:  J M Grimshaw; I T Russell
Journal:  Qual Health Care       Date:  1994-03

Review 5.  Achieving health gain through clinical guidelines. I: Developing scientifically valid guidelines.

Authors:  J Grimshaw; I Russell
Journal:  Qual Health Care       Date:  1993-12

Review 6.  Implementing guidelines in general practice care.

Authors:  R Grol
Journal:  Qual Health Care       Date:  1992-09

Review 7.  Personal paper. Beliefs and evidence in changing clinical practice.

Authors:  R Grol
Journal:  BMJ       Date:  1997-08-16

8.  Formal consensus: the development of a national clinical guideline.

Authors:  J Rycroft-Malone
Journal:  Qual Health Care       Date:  2001-12

9.  Evaluating the message: the relationship between compliance rate and the subject of a practice guideline.

Authors:  R Grilli; J Lomas
Journal:  Med Care       Date:  1994-03       Impact factor: 2.983

10.  Pharmacotherapeutic circles. Results of an 18-month peer-review prescribing-improvement programme for general practitioners.

Authors:  L von Ferber; J Bausch; I Köster; I Schubert; P Ihle
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.